250 related articles for article (PubMed ID: 24722438)
1. Overexpression of Mafb in podocytes protects against diabetic nephropathy.
Morito N; Yoh K; Ojima M; Okamura M; Nakamura M; Hamada M; Shimohata H; Moriguchi T; Yamagata K; Takahashi S
J Am Soc Nephrol; 2014 Nov; 25(11):2546-57. PubMed ID: 24722438
[TBL] [Abstract][Full Text] [Related]
2. MiR-320a induces diabetic nephropathy via inhibiting MafB.
He M; Wang J; Yin Z; Zhao Y; Hou H; Fan J; Li H; Wen Z; Tang J; Wang Y; Wang DW; Chen C
Aging (Albany NY); 2019 May; 11(10):3055-3079. PubMed ID: 31102503
[TBL] [Abstract][Full Text] [Related]
3. Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury.
Ito Y; Hsu MF; Bettaieb A; Koike S; Mello A; Calvo-Rubio M; Villalba JM; Haj FG
Metabolism; 2017 Nov; 76():56-69. PubMed ID: 28987240
[TBL] [Abstract][Full Text] [Related]
4. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F
Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678
[TBL] [Abstract][Full Text] [Related]
5. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-29a promotion of nephrin acetylation ameliorates hyperglycemia-induced podocyte dysfunction.
Lin CL; Lee PH; Hsu YC; Lei CC; Ko JY; Chuang PC; Huang YT; Wang SY; Wu SL; Chen YS; Chiang WC; Reiser J; Wang FS
J Am Soc Nephrol; 2014 Aug; 25(8):1698-709. PubMed ID: 24578127
[TBL] [Abstract][Full Text] [Related]
7. Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice.
Zhang H; Schin M; Saha J; Burke K; Holzman LB; Filipiak W; Saunders T; Xiang M; Heilig CW; Brosius FC
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F91-8. PubMed ID: 20375116
[TBL] [Abstract][Full Text] [Related]
8. Suppressed ER-associated degradation by intraglomerular cross talk between mesangial cells and podocytes causes podocyte injury in diabetic kidney disease.
Fujimoto D; Kuwabara T; Hata Y; Umemoto S; Kanki T; Nishiguchi Y; Mizumoto T; Hayata M; Kakizoe Y; Izumi Y; Takahashi S; Mukoyama M
FASEB J; 2020 Nov; 34(11):15577-15590. PubMed ID: 32996639
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
10. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
11. Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.
Tarabra E; Giunti S; Barutta F; Salvidio G; Burt D; Deferrari G; Gambino R; Vergola D; Pinach S; Perin PC; Camussi G; Gruden G
Diabetes; 2009 Sep; 58(9):2109-18. PubMed ID: 19587356
[TBL] [Abstract][Full Text] [Related]
12. Podocyte-specific knockin of PTEN protects kidney from hyperglycemia.
Wang H; Feng Z; Xie J; Wen F; Jv M; Liang T; Li J; Wang Y; Zuo Y; Li S; Li R; Li Z; Zhang B; Liang X; Liu S; Shi W; Wang W
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1096-F1107. PubMed ID: 29361670
[TBL] [Abstract][Full Text] [Related]
13. Podocyte RNF166 deficiency alleviates diabetic nephropathy by mitigating mitochondria impairment and apoptosis via regulation of CYLD signal.
Hongbo M; Yanjiao D; Shuo W; Kun S; Yanjie L; Mengmeng L
Biochem Biophys Res Commun; 2021 Mar; 545():46-53. PubMed ID: 33545631
[TBL] [Abstract][Full Text] [Related]
14. Increased SHP-1 protein expression by high glucose levels reduces nephrin phosphorylation in podocytes.
Denhez B; Lizotte F; Guimond MO; Jones N; Takano T; Geraldes P
J Biol Chem; 2015 Jan; 290(1):350-8. PubMed ID: 25404734
[TBL] [Abstract][Full Text] [Related]
15. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
16. Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1.
Lee HW; Khan SQ; Khaliqdina S; Altintas MM; Grahammer F; Zhao JL; Koh KH; Tardi NJ; Faridi MH; Geraghty T; Cimbaluk DJ; Susztak K; Moita LF; Baltimore D; Tharaux PL; Huber TB; Kretzler M; Bitzer M; Reiser J; Gupta V
J Biol Chem; 2017 Jan; 292(2):732-747. PubMed ID: 27913625
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MALAT1 is dysregulated in diabetic nephropathy and involved in high glucose-induced podocyte injury via its interplay with β-catenin.
Hu M; Wang R; Li X; Fan M; Lin J; Zhen J; Chen L; Lv Z
J Cell Mol Med; 2017 Nov; 21(11):2732-2747. PubMed ID: 28444861
[TBL] [Abstract][Full Text] [Related]
18. Persistent Insulin Resistance in Podocytes Caused by Epigenetic Changes of SHP-1 in Diabetes.
Lizotte F; Denhez B; Guay A; Gévry N; Côté AM; Geraldes P
Diabetes; 2016 Dec; 65(12):3705-3717. PubMed ID: 27585521
[TBL] [Abstract][Full Text] [Related]
19. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
20. Modulation of glutathione peroxidase activity by age-dependent carbonylation in glomeruli of diabetic mice.
Wiedenmann T; Dietrich N; Fleming T; Altamura S; Deelman LE; Henning RH; Muckenthaler MU; Nawroth PP; Hammes HP; Wagner AH; Hecker M
J Diabetes Complications; 2018 Feb; 32(2):130-138. PubMed ID: 29223856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
